Biotech developing kidney disease treatment jumps after hedge fund recommendation at conference

France Nouvelles Nouvelles

Biotech developing kidney disease treatment jumps after hedge fund recommendation at conference
France Dernières Nouvelles,France Actualités
  • 📰 CNBC
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Bihua Chen, founder and portfolio manager at Cormorant Asset Management, said on Monday she likes kidney drugmaker Reata Pharmaceutical.

The kidney drug that Reata is developing called Bardoxolone has "striking efficacy," Bihua Chen says.Adam Jeffery | CNBC

Bihua Chen, founder and portfolio manager at Cormorant Asset Management, said on Monday she likes kidney disease drug makerThe kidney drug that Reata is developing called Bardoxolone has "striking efficacy," the hedge fund manager said from the Sohn Conference in New York.Chen pointed out there are concerns about the new drug that could lead to heart failure and weight loss, but she said based on her research on the drug trails, she's not worried about the safety issue.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

CNBC /  🏆 12. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Here are the stock picks from the rising hedge fund stars at the Sohn conferenceHere are the stock picks from the rising hedge fund stars at the Sohn conferenceHere are the top investment ideas from the 'Next Wave' panel at the Sohn Investment Conference in New York.
Lire la suite »

Ray Dalio, the hedge fund manager decrying wealth inequality, made $2 billion last yearRay Dalio, the hedge fund manager decrying wealth inequality, made $2 billion last yearRay Dalio, the founder of the biggest hedge fund in the world, was the highest-paid hedge-fund manager in the world last year.
Lire la suite »

Cabot Oil & Gas rises after hedge fund names it a top pickCabot Oil & Gas rises after hedge fund names it a top pickMatthew Smith of Deep Basin Capital, a nascent energy-focused fund based in Stamford, Connecticut, said he's long Cabot thanks to the company's solid production.
Lire la suite »

Human hedge fund managers embrace robot-rival tools to amp returnsHuman hedge fund managers embrace robot-rival tools to amp returnsTraditional stock-pickers in the hedge fund world have been struggling to justif...
Lire la suite »

Bridgewater Co-CEO Eileen Murray Weighs Leaving World’s Largest Hedge FundBridgewater Co-CEO Eileen Murray Weighs Leaving World’s Largest Hedge FundBridgewater co-CEO Eileen Murray has held repeated conversations inside and outside of the firm about leaving the world’s largest hedge fund.
Lire la suite »

Meet the 5 rising stars presenting their investment ideas at the world's highest-profile hedge-fund conferenceMeet the 5 rising stars presenting their investment ideas at the world's highest-profile hedge-fund conferenceFor first time since Sohn began its 'Next Wave' series six years ago, the majority of presenters identified as rising stars on Wall Street are not white men.
Lire la suite »

Jefferies helped a rogue hedge fund partner trade with tons of leverage that bankrupted his fund, a new ruling findsJefferies helped a rogue hedge fund partner trade with tons of leverage that bankrupted his fund, a new ruling findsCarbon Investment Partners closed after one of its partners, Lee Bressler, lost on extremely leveraged trades on Tesla and Amazon. An arbitrator found that Jefferies' prime brokerage helped him do it.
Lire la suite »

Netflix's 'This is Dementia': Alzheimer's scientist on what the disease is, treatments and how it can be preventedNetflix's 'This is Dementia': Alzheimer's scientist on what the disease is, treatments and how it can be prevented'It's sad, but most people can't even tell you what the word dementia means,' Dr. John W. DenBoer told 'Newsweek.'
Lire la suite »



Render Time: 2025-03-09 16:15:11